title: Breast cancer genome heterogeneity: a challenge to personalised medicine?
abstract: Implementation of high-throughput genomics sequencing approaches into routine laboratory practice has raised the potential for the identification of multiple breast cancer targets suitable for future therapeutic intervention in order to improve cancer outcomes. Results from these studies have revealed bewildering breast cancer genome complexity with very few aberrations occurring in common between breast cancers. In addition, such complexity is compounded by evidence of genomic heterogeneity occurring within individual breast cancers. Such inter-tumoural and intratumoural heterogeneity is likely to present a challenge to personalised therapeutic approaches that might be circumvented through the definition of genome instability mechanisms governing such diversity and their exploitation using synthetic lethal approaches.
authors.forename: Charles
authors.initials: C
authors.lastname: Swanton
authors.forename: Rebecca A
authors.initials: RA
authors.lastname: Burrell
authors.forename: P Andrew
authors.initials: PA
authors.lastname: Futreal
mesh_terms: D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D005260:Female; D018740:Genetic Heterogeneity; D015894:Genome, Human; D006801:Humans; D057285:Precision Medicine